Previous 10 | Next 10 |
Lilly Declares Third-Quarter 2024 Dividend PR Newswire INDIANAPOLIS , June 24, 2024 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the third quarter of 2024 of $1.30 per share on outstanding common stoc...
2024-06-24 11:14:09 ET This week marks the last handful of trading days for H1 2024, as market participants watched so far this year the benchmark S&P 500 ( SP500 ) advance 15.1% year to date.... Read the full article on Seeking Alpha For further details see: Top...
2024-06-24 09:21:19 ET More on Altimmune Altimmune: Going All-In On Pemvidutide Altimmune: A Potential Minor Player In The Massive GLP-1 Space Altimmune's Pemvidutide Is Not To Be Dismissed Altimmune Q1 2024 Earnings Preview Altimmune falls after Q4 r...
2024-06-24 09:00:07 ET Akash Tewari from Jefferies issued a price target of $1,015.00 for LLY on 2024-06-24 07:53:00. The adjusted price target was set to $1,015.00. At the time of the announcement, LLY was trading at $883.88. The overall price target consensus is at $60...
2024-06-24 04:53:13 ET Summary Follow along as we discuss a potential top formation in Lilly's stock price and the importance of proper evidence before taking a short position. We share our methodology that shows at what price level to turn more cautious if you are long Lilly shar...
2024-06-23 14:00:00 ET More on Eli Lilly, Novo Nordisk Eli Lilly: The Party Is Probably Nearing The End Novo Nordisk: Leading The Fight Against Diabetes And Obesity SA Asks: Who will launch the next big weight-loss drug? SA Asks: Is Eli Lilly or Novo No...
2024-06-22 19:33:06 ET The AI driven massive surge in Nvidia Corp has pushed it market cap well above the $3.0 trillion mark. Meanwhile, these three stocks look ripe to hit their first trillion in valuation. Let’s dive deeper and see what each of these have in store for inves...
2024-06-22 11:00:00 ET More on Eli Lilly, Novo Nordisk, etc. Eli Lilly: The Party Is Probably Nearing The End Novo Nordisk: Leading The Fight Against Diabetes And Obesity Eli Lilly And Alzheimer's Disease: The Paucity Of Progress ResMed, Philips under pressur...
2024-06-22 08:27:42 ET More on Eli Lilly, Philips, etc. Eli Lilly: The Party Is Probably Nearing The End Eli Lilly And Alzheimer's Disease: The Paucity Of Progress Eli Lilly: The Road To Approval Of Donanemab Is Open Lilly weight loss drug tirzepatide meets p...
2024-06-21 16:33:06 ET More on Takeda Pharmaceutical Takeda: Strong Growth Catalysts And Maturing Pipeline Continue To Limit Downside Risk Takeda Pharmaceutical Company Limited (TAK) Fiscal Year 2023 Earnings Call Transcript Takeda Pharmaceutical Company Limited 2023...
News, Short Squeeze, Breakout and More Instantly...
2024-07-27 07:15:00 ET According to some research, bull markets tend to last an average of 2.6 years. The one we are currently experiencing has been going on for almost two years -- maybe it will soon end, maybe it won't. Equities that can perform well throughout bull runs might be good to ...
2024-07-26 07:45:00 ET Over the last 18 months, the stock market has been incredibly generous to investors. Since January 2023, the S&P 500 has soared 45%, while the tech-heavy Nasdaq Composite has rocketed by 72%. Outside of the technology industry, investors have also foun...
2024-07-25 19:06:06 ET It wasn't so long ago when Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) stocks were flying high thanks to their hotly popular weight loss drugs (Wegovy/Ozempic for Novo Nordisk and Zepbound/Mounjaro for Lilly). In the pharmaceutical industry,...